Key Takeaways
- Sun Pharmaceutical Industries Ltd. reported revenues of Rs.2683.5 crore in Q1FY13 v/s Rs.2336.2 crore in Q1 FY12.
- EBITDA is Rs.1242.2 crore in Q1 FY13 v/s Rs.548.9 crore in Q1 FY12.
- EBIDTA margins were 46.3% in Q1 FY13 v/s 33.5% in Q1 FY12.
- The company posted a net profit of Rs.795.6 crore in this quarter v/s market expectations of Rs.671 crore.
- PAT margins increased by 10 bps from 30.6% in Q1 FY12 to 29.6% in Q1 FY13.
Outlook: Results better than market expectations.